Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC17276 Monomethyl auristatin E

    一甲基澳瑞他汀E,Vedotin; MMAE

    Monomethyl Auristatin E (MMAE),作为海兔毒素 10 的合成衍生物,海兔毒素 10 是一种线性五肽,最初是从海兔 Dolabella auriculari 的提取物中分离出来的。
  3. GC17802 MK-4827

    尼拉帕尼; MK-4827

    An orally bioavailable PARP1/2 inhibitor
  4. GC12199 MI-3

    Menin-MLL inhibitor 3;Thieno[2,3-d]pyrimidine, 4-[4-(4,5-dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-(1-methylethyl)-

    An inhibitor of menin-MLL fusion protein interactions
  5. GC11418 MI-2

    Menin-MLL inhibitor 2;Thieno[2,3-d]pyrimidine, 4-[4-(4,5-dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-propyl-

    An inhibitor of menin-MLL fusion protein interactions
  6. GC17874 Matrine

    苦参碱; Matridin-15-one; Vegard; α-Matrine

    苦参碱(Matrine)是一种存在于槐属植物中的生物碱,可作为 kappa 阿片受体和µ-受体激动剂。
  7. GC12045 LY 303511

    8-苯基-2-(1-哌嗪基)-4H-1-苯并吡喃-4-酮,LY-303511;LY303511

    An inhibitor of cell proliferation
  8. GC10809 LRRK2-IN-1

    5,11-二氢-2-[[2-甲氧基-4-[[4-(4-甲基-1-哌嗪基)-1-哌啶基]羰基]苯基]氨基]-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮,LRRK 2-IN-1

    A selective LRRK2 inhibitor
  9. GC16589 Limonin

    柠檬苦素; Limonoic acid 3,19

    柠檬苦素是一种天然的四环三萜类化合物,广泛存在于桉树、黄柏和黄连中。
  10. GC14015 Lenalidomide hydrochloride

    Revlimid hydrochloride;CC-5013 hydrochloride;CC5013 hydrochloride;CC 5013 hydrochloride

    An analog of thalidomide
  11. GC14291 LCL161

    LCL-161;LCL 161

    A Smac mimetic and inhibitor of IAP family proteins
  12. GC11319 kb NB 142-70

    3,4-二氢-9-羟基-[1]苯并噻吩并[2,3-F]-1,4-硫氮杂卓-5(2H)-酮

    A selective PKD inhibitor
  13. GC16869 Ixabepilone

    伊沙匹隆; BMS-247550; Aza-epothilone B

    A broad-spectrum anticancer agent
  14. GC13795 Isobavachalcone

    补骨脂乙素; Corylifolinin; Isobacachalcone

    A chalcone and flavonoid with diverse biological activities
  15. GC15659 GSK-923295

    3-氯-N-{(1S)-2-[(N,N-二甲基甘氨酰)氨基]-1-[(4-{8-[(1S)-1-羟基乙基]咪唑并[1,2-A]吡啶-2-基}苯基)甲基]乙基}-4-[(1-甲基乙基)氧基]苯甲酰胺,GSK 923295;GSK923295

    An inhibitor of CENP-E
  16. GC17450 GSK2606414

    GSK 2606414;GSK-2606414

    GSK2606414是一种具有口服活性的选择性蛋白激酶R样内质网激酶(PERK)抑制剂,IC50值为0.4nM。
  17. GC12555 GS-9620

    维沙莫德; GS-9620

    A TLR7 agonist
  18. GC12139 Gambogic Acid

    藤黄酸; Beta-Guttiferrin

    Gambogic Acid 是一种细胞渗透性 caspase 激活剂和细胞凋亡诱导剂,常用于乳腺癌、肺癌和肝癌等的研究。
  19. GC17851 D609

    D609钾盐,D-609 potassium, D 609, D-609

    A competitive inhibitor of PC-specific PLC
  20. GC13202 D4476

    4-[4-(2,3-二氢-1,4-苯并二氧杂环己-6-基)-5-(2-吡啶基)-1H-咪唑-2-基]苯甲酰胺,Casein Kinase I Inhibitor;D 4476;D-4476

    Inhibitor of CK1 and ALK5
  21. GC14787 Curcumin

    姜黄素; Diferuloylmethane; Natural Yellow 3; Turmeric yellow

    A yellow pigment with diverse biological activities

  22. GC16116 Costunolide

    木香烃内酯; (+)-Costunolide; Costus lactone

    A natural sesquiterpene lactone
  23. GC10033 Cobimetinib

    考比替尼; GDC-0973; XL518

    A potent, orally available MEK1 inhibitor
  24. GC13065 Chelerythrine Chloride

    盐酸白屈菜红碱

    Potent inhibitor of PKC and Bcl-xL
  25. GC17918 Capsazepine

    辣椒平

    Capsazepine是瞬时受体电位香草素1(TRPV1)受体的特异性拮抗剂,IC50值为562 nM。
  26. GC14065 Capsaicin

    辣椒素; (E)-Capsaicin

    辣椒素是一种高度选择性的瞬时受体电位阳离子通道激动剂,亚家族 V,成员 1 (TRPV1),一种配体门控的非选择性阳离子通道,优先在小直径感觉神经元上表达 < /sup>。
  27. GC11632 Brassinolide

    油菜素内酯; Brassin lactone

    Brassinolide是一种植物甾醇,最初从油菜(Brassica napus L.)花粉中分离出来,在植物生长、发育和逆境耐受性方面发挥重要作用。
  28. GC13628 BMS-833923

    BMS 833923;BMS833923;XL-139;XL139;XL 139

    An orally bioavailable Smo inhibitor
  29. GC10480 Betulinic acid

    白桦脂酸; Lupatic acid; Betulic acid

    白桦脂酸(Betulinic acid)是一种天然的五环三萜类化合物,是真核细胞拓扑异构酶I的抑制剂,IC50值为5μM。
  30. GC12136 BAY 61-3606 dihydrochloride

    BAY61-3606 dihydrochloride;BAY 61-3606

    BAY 61-3606 dihydrochloride 是一种可口服的、ATP 竞争性、可逆和高选择性的 Syk 抑制剂,Ki 为 7.5 nM,IC50 为 10 nM。
  31. GC16389 BAY 61-3606

    2-[[7-(3,4-二甲氧基苯基)咪唑并[1,2-C]嘧啶-5-基]氨基]-3-吡啶甲酰胺,BAY61-3606

    A Syk inhibitor
  32. GC11572 Bardoxolone methyl

    甲基巴多索隆; RTA 402; NSC 713200; CDDO Methyl ester

    A synthetic triterpenoid with potent anticancer and antidiabetic activity
  33. GC15371 Bardoxolone

    2-氰基-3,12-二氧代齐墩果-1,9-二烯-28-酸,CDDO;RTA 401;RTA401;RTA-401

    An anti-inflammatory compound that activates Nrf2/ARE signaling
  34. GC12053 BAM7

    BAM 7;BAM-7

    A direct activator of Bax
  35. GC17045 AXL1717

    苦鬼臼毒素; AXL1717; Picropodophyllin; PPP

    A potent and selective inhibitor of IGF-1R
  36. GC13998 AT7519 Hydrochloride

    N-(4-哌啶基)-4-(2,6-二氯苄氨基)-1H-吡唑-3-羧胺盐酸盐,AT 7519 Hydrochloride;AT-7519 Hydrochloride

    A Cdk inhibitor
  37. GC11106 AT-101

    (-)-棉子素,(R)-(-)-Gossypol;R-(-)-gossypol acetic acid;AT 101;AT101

    AT-101 (AT-101) 是天然产物棉酚的左旋异构体。 AT-101 与 Bcl-2、Mcl-1 和 Bcl-xL 蛋白结合,Kis 分别为 260±30 nM、170±10 nM 和 480±40 nM。
  38. GC13215 Ascomycin(FK 520)

    子囊霉素; Immunomycin; FR-900520; FK520

    A potent macrolide immunosuppressant
  39. GC11589 AKT inhibitor VIII

    1,3-二氢-1-[1-[[4-(6-苯基-1H-咪唑并[4,5-G]喹喔啉-7-基)苯基]甲基]-4-哌啶基]-2H-苯并咪唑-2-酮,AKTi-1/2

    A potent inhibitor of Akt1 and Akt2
  40. GC13959 Adarotene

    (2E)-3-(4'-羟基-3'-金刚烷-1-基[1,1'-联苯]-4-基)-2-丙烯酸,ST 1926;ST-1926;ST1926

    An atypical retinoid
  41. GC13805 Abacavir

    阿巴卡韦

    阿巴卡韦是一种具有口服活性和竞争性的核苷类逆转录酶抑制剂。
  42. GC12791 3,3'-Diindolylmethane

    3,3'-二吲哚甲烷,diindolylmethane, 3,3'-Methylenediindole,DIM,Arundine,HB236

    A phytochemical with antiradiation and chemopreventative effects
  43. GC16684 Docetaxel

    多西他赛; RP-56976

    Docetaxel是紫杉烷类抗有丝分裂化疗药物,IC50为0.2 µM。
  44. GC11610 Pemetrexed

    培美曲塞二钠盐; LY231514 disodium

    An antifolate with anticancer activity
  45. GC13885 Elesclomol (STA-4783)

    伊利司莫; STA-4783

    Elesclomol(也称为 STA-4783)最初是在基于细胞的表型筛选中发现的促凋亡活性,是一种新型小分子,可通过快速产生活性氧 (ROS) 有效诱导癌细胞凋亡以及难以控制的氧化应激水平的诱导。
  46. GC17655 Ganetespib (STA-9090)

    STA9090, STA 9090

    Ganetespib (STA-9090) (STA-9090) 是一种热休克蛋白 90 (HSP90) 抑制剂,在多种血液和实体肿瘤细胞系中表现出强效细胞毒性。 Ganetespib (STA-9090) 通过抑制 HIF-1α 在结直肠癌中具有抗血管生成作用;和 STAT3。
  47. GC12801 Rasagiline Mesylate

    甲磺酸雷沙吉兰; (R)-AGN1135 mesylate; TVP1012 mesylate

    An inhibitor of MAO-B
  48. GC17107 PluriSIn #1 (NSC 14613)

    NSC 14613

    A selective inhibitor of stearoyl-CoA desaturase
  49. GC12919 Pralatrexate

    普拉曲沙

    A dihydrofolate reductase inhibitor
  50. GC10077 S- (+)-Rolipram

    (+)-Rolipram; (S)-Rolipram

    S- (+)-Rolipram ((+)-Rolipram) 是一种环状 AMP(cAMP) 特异性磷酸二酯酶 4 (PDE4) 抑制剂,IC50 为 1100 nM。
  51. GC10405 Methotrexate

    甲氨蝶呤; Amethopterin; CL14377; WR19039

    甲氨蝶呤(Methotrexate)是一种抗叶酸类抗代谢药,有效抑制二氢叶酸还原酶(DHFR)活性,IC50约为7nM。

Items 2451 to 2500 of 2733 total

per page

Set Descending Direction